A comparison of samples wild type or mutant for the NRF2 pathway demonstrated a highly significant enrichment of mRNA for all four AKR genes in mutant cases, in both AC and SCC ( Figure 4 ).
← all excerpts
Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer.
1
—
—